BGB-283-CN-001

Completed

The Study of BGB-283 in Chinese Subjects With Local Advanced or Metastatic Malignant Solid Tumor

Beigene Study ID info

BGB-283-CN-001

ClinicalTrials.gov ID info

China Drug Trials ID info

CTR20150575

Study Overview

Sex: All

Age: 18 Years to 75 Years   (Adult, Older Adult)

No Study Documents

Study Overview

Sex: All

Age: 18 Years to 75 Years   (Adult, Older Adult)

No Study Documents